Citigroup Inc Mannkind Corp Transaction History
Citigroup Inc
- $163 Billion
- Q4 2024
A detailed history of Citigroup Inc transactions in Mannkind Corp stock. As of the latest transaction made, Citigroup Inc holds 360,414 shares of MNKD stock, worth $2.02 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
360,414
Previous 196,717
83.21%
Holding current value
$2.02 Million
Previous $1.24 Million
87.61%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding MNKD
# of Institutions
253Shares Held
155MCall Options Held
1.62MPut Options Held
802K-
Black Rock Inc. New York, NY22.6MShares$126 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.1MShares$89.9 Million0.0% of portfolio
-
State Street Corp Boston, MA9.6MShares$53.7 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY9.16MShares$51.3 Million6.38% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.75MShares$49 Million0.83% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.44B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...